SPY458.97-10.47 -2.23%
DIA349.02-9.01 -2.52%
IXIC15,491.66-353.57 -2.23%

Stealth BioTherapeutics Q3 EPS $(0.01) Beats $(0.02) Estimate

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent increase over losses of $(0.02) per share from

Benzinga · 11/11/2021 07:32
Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.